Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Coffee drinkers appear to have a 49% lower risk of dying of chronic liver disease.
A wide variety of research studies show there are benefits of coffee consumption for hepatitis C and liver disease.
Researchers found that more than 700,000 fewer people would die if the per capita coffee consumption were four or more cups per day.
Research proved that those with liver disease may reduce fibrosis by drinking 1 to 3 cups of this dark brew each day.
Drinking coffee as well as healthy eating can help liver disease patients. But there are some suggested recommendations to keep in mind.
There isn’t evidence to either prove or disprove the effectiveness of colon cleansing or coffee enemas.
Research shows that increased consumption of coffee and cannabis may reduce the risk for early death from hepatitis C infection.
This finding held true even when the researchers restricted their analysis to caffeine from soft drinks.
Scientific evidence does not support warning signs about acrylamide cancer risk.
Controversial ruling relates to a chemical produced in the roasting process.
Studies suggest it reduces the risk of liver cancer—and possibly other types as well.
A new roundtable report summarizes key findings from recent studies outlining coffee’s likely contributions to protecting the liver.
Other factors linked to a reduced risk of death include a hep C cure, less advanced liver disease, not smoking and well treated HIV.
If you’re a diehard coffee lover, here’s another reason to indulge.
Two new studies presented at IAS 2017 shed more light on how our daily habits may affect liver disease risk.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.